|
|
|
19.03.26 - 13:18
|
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer (Business Wire)
|
|
|
Busch brings public company leadership and capital markets experience to support Ignite's next phase of growthMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”).
Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most likely to work for each patient.
Mr. Busch is the Founder, Chairman, and former Chief Executive Officer of Chiron Real Estate Inc. (NYSE: XRN), formerly Global Medical REIT (NYSE: GMRE), a company he founded, bringing public company leadership and capital markets exp...
|
|
|
11.02.26 - 22:18
|
Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast (Business Wire)
|
|
|
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley.
Please note, at the time it releases its fourth quarter and year-end 2025 financial results, the Company's previously announced name change to Chiron Real Estate Inc. will have taken effect.
Webcast Information
Participants may access the call via live webcast by visiting the “Investor Relations” section of the Company's new website at www.chironre.com/investor/investor-overview/default.asp...
|
|
|
|
|
27.01.26 - 14:06
|
Global Medical REIT Reports Tax Treatment of 2025 Dividends (Business Wire)
|
|
|
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link.
https://investors.globalmedicalreit.com/stock-data/dividend-tax-information
Note: Data for common dividends paid in January, April and July 2025 have been adjusted to reflect the Company's one-for-five reverse stock split that was effective on September 19, 2025.
Stockholders should review their Forms 1099 as well as other 2025 tax statements that they will receive from their brokerage firms or other institutions to ensure that the statements agree with the information posted. Additionally, stockholders are encouraged to consult with their own professional tax advisors with respect to their individual tax consequences.
ABOUT GLOBAL MEDICAL REIT
Global Medical REIT Inc. is a...
|
|
|
26.01.26 - 22:06
|
Global Medical REIT Inc. Announces Henry Cole Stepping Down from its Board of Directors (Business Wire)
|
|
|
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Henry Cole has notified the Board of Directors (the “Board”) that he plans to step down as a member of the Board at the end of his current term.
Henry Cole's Stepping Down from Board of Directors
Mr. Cole has served on the Board as an Independent Director since the Company's inception and has served at different points throughout his term as the Board's Lead Independent Director, Chair of the Board's Compensation Committee and ESG Committee and as a member of the Board's Audit and Nominating and Corporate Governance Committees.
Mr. Cole will be stepping down effective at the end of his current term, which will conclude at the Company's Annual Meeting of Stockholders to be held in 2026.
Jeffrey Busch, the Chairman of the Board commented, “the Board would like to thank Henry for his strong leadership and his broad and meaningful contributions throughout the history of the ...
|
|
|
|
|
|
|
|
|
04.12.25 - 22:15
|
Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends (Business Wire)
|
|
|
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends.
Ronald Marston's Retirement from Board of Directors
Mr. Marston has served on the Board since 2015 as an independent director and at different points throughout his tenure has served as the chair of the Board's Nominating and Corporate Governance Committee as well as a member of the Board's Audit and Compensation Committees. Mr. Marston's retirement will be effective at the end of his current term, which will conclude at the Company's Annual Meeting of Stockholders to be held in 2026.
Lori Wittman, the Board's lead independent director commented, “the Board would like to thank Ron for his leadership and significant contributions th...
|
|
|
14.11.25 - 04:36
|
Global Medical REIT Inc. Announces Pricing of Public Offering of 8.00% Series B Preferred Stock (Business Wire)
|
|
|
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on November 20, 2025, subject to customary closing conditions. The Company expects to receive gross proceeds of approximately $50,000,000, before deducting underwriting discounts and commissions and estimated offering expenses. The Company has granted the underwriters a 30-day option to purchase up to an additional 300,000 shares of Series B Preferred Stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
The Company intends to use the net proceeds from this offering for general corporate purposes, which may include funding new acquisiti...
|
|
|
|
|
|
|
13.11.25 - 14:48
|
Global Medical REIT Inc. Announces Proposed Public Offering of Series B Preferred Stock (Business Wire)
|
|
|
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the commencement of an underwritten public offering of shares of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”), subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional shares of Series B Preferred Stock to cover over-allotments, if any. The Company intends to use the net proceeds from the offering for general corporate purposes, which may include funding new acquisitions and repaying indebtedness, including amounts outstanding under the Company's credit facility.
The Company intends to apply to list the Series B Preferred Stock on the New York Stock Exchange under the ticker symbol “GMRE-PrB.”
Raymond James, BMO Capital Markets, Stifel and Baird are serving as the book-running managers for the offering.
The offering is being made pursuant to the Company's shelf re...
|
|
|
|
|
24.09.25 - 15:21
|
XFRA: 3UN0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
GLOBAL MED REIT DL.-,001 3UN0 US37954A3032
AB/FROM ONWARDS 24.09.2025 15:13 CET...
|
|
|
22.09.25 - 11:27
|
XFRA: 3UN0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
GLOBAL MED REIT DL.-,001 3UN0 US37954A3032 BAW/UFN...
|
|
|
|
|
19.09.25 - 16:42
|
XFRA: ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA70337R1073 Patriot Battery Metals Inc. 19.09.2025 CA73015G1046 PMET Resources Inc. 22.09.2025 Tausch 1:1
US37954A2042 Global Medical REIT Inc. 19.09.2025 US37954A3032 Global Medical REIT Inc. 22.09.2025 Tausch 5:1
CA6739101054 New Earth Resources Corp. 19.09.2025 CA6438181076 New Earth Resources Corp. 22.09.2025 Tausch 10:1...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
